Navas-Martin S - Search Results

1

SARS: lessons learned from other coronaviruses.

Navas-Martin S, Weiss SR. Navas-Martin S, et al. Viral Immunol. 2003;16(4):461-74. doi: 10.1089/088282403771926292. Viral Immunol. 2003. PMID: 14733734 Review.

2

Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development.

Navas-Martín SR, Weiss S. Navas-Martín SR, et al. J Neurovirol. 2004 Apr;10(2):75-85. doi: 10.1080/13550280490280292. J Neurovirol. 2004. PMID: 15204926 Free PMC article. Review.

3

Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein.

Navas-Martin S, Hingley ST, Weiss SR. Navas-Martin S, et al. J Virol. 2005 Jun;79(12):7629-40. doi: 10.1128/JVI.79.12.7629-7640.2005. J Virol. 2005. PMID: 15919915 Free PMC article.

4

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.

Weiss SR, Navas-Martin S. Weiss SR, et al. Microbiol Mol Biol Rev. 2005 Dec;69(4):635-64. doi: 10.1128/MMBR.69.4.635-664.2005. Microbiol Mol Biol Rev. 2005. PMID: 16339739 Free PMC article. Review.

5

Replicase genes of murine coronavirus strains A59 and JHM are interchangeable: differences in pathogenesis map to the 3' one-third of the genome.

Navas-Martin S, Brom M, Chua MM, Watson R, Qiu Z, Weiss SR. Navas-Martin S, et al. J Virol. 2007 Jan;81(2):1022-6. doi: 10.1128/JVI.01944-06. Epub 2006 Nov 1. J Virol. 2007. PMID: 17079303 Free PMC article.

6

Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design.

Toney JH, Navas-Martín S, Weiss SR, Koeller A. Toney JH, et al. J Med Chem. 2004 Feb 26;47(5):1079-80. doi: 10.1021/jm034137m. J Med Chem. 2004. PMID: 14971887

7

Role of the replicase gene of murine coronavirus JHM strain in hepatitis.

Navas-Martín S, Brom M, Weiss SR. Navas-Martín S, et al. Adv Exp Med Biol. 2006;581:415-20. doi: 10.1007/978-0-387-33012-9_75. Adv Exp Med Biol. 2006. PMID: 17037571 Free PMC article. No abstract available.

8

Expression and purification of SARS coronavirus proteins using SUMO-fusions.

Zuo X, Mattern MR, Tan R, Li S, Hall J, Sterner DE, Shoo J, Tran H, Lim P, Sarafianos SG, Kazi L, Navas-Martin S, Weiss SR, Butt TR. Zuo X, et al. Protein Expr Purif. 2005 Jul;42(1):100-10. doi: 10.1016/j.pep.2005.02.004. Epub 2005 Feb 23. Protein Expr Purif. 2005. PMID: 15939295 Free PMC article.

9

Toll-like receptor 3 in viral pathogenesis: friend or foe?

Perales-Linares R, Navas-Martin S. Perales-Linares R, et al. Among authors: navas martin s. Immunology. 2013 Oct;140(2):153-67. doi: 10.1111/imm.12143. Immunology. 2013. PMID: 23909285 Free PMC article. Review.

10

Protective role of Toll-like Receptor 3-induced type I interferon in murine coronavirus infection of macrophages.

Mazaleuskaya L, Veltrop R, Ikpeze N, Martin-Garcia J, Navas-Martin S. Mazaleuskaya L, et al. Viruses. 2012 May;4(5):901-23. doi: 10.3390/v4050901. Epub 2012 May 24. Viruses. 2012. PMID: 22754655 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters